Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma

NCT00881049 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma

Interventions

DRUG: Imatinib (Gleevec)

Sponsor

Peking University

Collaborators

[object Object]